Home     Events     CD/Documentation     Training     About Us     Contact Us     Help     Your Basket  
The SMi Group
  
 
  Advanced Search
  User Log-In / Register
Events Home Page
Events Calendar
Venue Information
Accommodation
Speaker Opportunities
Marketing Opportunities
Sponsors & Exhibitions
Supplementary Info...
The CPD Certification Service
 
SMi is a member of
the CPD service
 
smi conferences - pharmaceuticals - events
Conferences Executive Briefings Masterclasses Search Events Other Sectors
Overview Programme Associated Events Sponsors Supporters Register Now
Add to Basket   Fax Order Form   Sponsorship/Exhibition Enquiry   Send to a Friend  

RNAi, siRNA & miRNA



associated eventsMicroRNAs and Oncology Drug Development
Delivery of Oligonucleotide-Based Drugs

overview

RNA interference (RNAi) has the potential to become big business for all those involved.  Less than 10 years after its discovery by Andrew Fire, Craig Mello and co-workers, since rewarded for their research with a Nobel Prize in 2006, this discovery is being touted as the new innovation craved by the pharmaceutical industry. 
 

RNAi therapeutics research is still in the early stages of development, and therefore currently essentially not validated, making learning from the mistakes and successes of others working in this field is invaluable. With the market estimated to be worth more than $3 billion in 2007, and growing, this is one area of research Pharma can’t afford not to be involved in.

 
SMi’s 4th RNAi, siRNA & miRNA conference aims to bring together industry experts from both large Pharma and smaller biotechs to discuss the successes and pitfalls of their research into this area.  Covering developments in therapeutics, and providing a critical overview of current RNAi therapeutics this conference could prove to be the insight needed to boost your companies profile in the RNAi and related oligonucleotides field.


Why should you attend this event?

  • GAIN an insight into the latest developments in the RNA field
  • HEAR from leaders in the RNA field
  • DISCOVER ways to overcome delivery challenges
  • UNDERSTAND the latest deveopments in RNAi, siRNA & miRNA
  • EVALUATE the applicability of ncRNA methods to your research


Hear keynote addresses from:

  • Jörg Vollmer, Managing Director, Coley Pharmaceuticals (A Pfizer Company)
  • Troels Koch, VP, Research Division, Santaris Pharma
  • Michael Keller, Senior Fellow, Global siRNA Expert Technical Research&Development, Novartis


Our expert speaker line-up also includes:

  • Sterghios Moschos, Senior Scientist, Pfizer
  • Ansgar Santel, Senior Scientist, Silence Therapeutics
  • Ernst Wagner, Chair, Pharmaceutical Biology - Biotechnology, University of Munich
  • Roberto Guerciolini, SVP Pharmaceutical Development, Dicerna Pharmaceuticals
  • Satish Chandran, Chief Technology Officer, Pfizer
  • Chris Kitson, Group Leader, Gene Interference, GlaxoSmithKline
  • Tejdip Singh, Medical Director, Pharmacovigilance, Genzyme
  • Bruce Taillon, Director of Healthcare Business Development, Roche
  • Mark Edbrooke, Head of Gene Modulation, GlaxoSmithKline
  • Irena Ivanovska, Senior Research Biologist, Rosetta Inpharmatics (Merck)
  • Joachim Engels, Professor, University of Frankfurt
  • Georg Sczakiel, Professor, Universitat zu Lubeck
  • Petr Svoboda, Department of Epigenetic Regulations, Institute of Molecular Genetics
  • Søren Møller, Vice President, R&D, Exiqon


Who should attend?

This conference will be beneficial to those working in:
  • Pharmaceutical companies (scientists, business development, directors, executives and vice presidents)
  • Biotech companies (scientists, business development, directors, executives and vice presidents)
  • Biopharmaceutical companies (scientists, business development, directors, executives and vice presidents)
  • Academic researchers
  • Established and start-up companies in the RNAi and microRNA market spaces
Delegates at last years conference included representatives from the following companies:
  • F. Hoffman - La Roche
  • GlaxoSmithKline
  • Pfizer
  • Novartis
  • Genzyme
  • Johnson & Johnson
  • AstraZeneca
  • Genentech
  • Amgen
  • Silence Therapeutics
  • RXi Pharmaceuticals
  • Roche Diagnostics

This conference is an unmissable opportunity to raise the profile of your company amongst the market leaders in this area.

 
 
For speaker opportunities please contact Rachel Francis on +44 (0)20 7827 6056 or email rfrancis@smi-online.co.uk
 
For sponsorship opportunities please contact Alia Malick on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk


Venue details

Crowne Plaza St James London
 
.
45-51 Buckingham Gate
London
 
SW1E 6AF
 
Tel: +44 (0) 207 834 6655
Fax: +44 (0) 207 6307
 

 

.
.
 

 
Crowne Plaza St James London is a traditional deluxe hotel right in the heart of the city, perfectly situated for all your business and leisure needs.  In the heart of Westminster, it is just a stones throw away from Buckingham Palace, The Houses of Parliament, the London Eye and Victoria Station.

The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food and Bank Westminster with a modern British menu.  A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.
 
Nearest train stations:
• Victoria Station, 7 minutes’ walk
• Waterloo Station, 10 minutes by car

Underground stations
• St James’s Park, 5 minutes’ walk (District and Circle lines)
• Victoria Station, 7 minutes' walk (Victoria, District and Circle lines)

From St. James's Park Underground Station to the Hotel
Take the main St James’s Park exit and turn left into Petty France Street.
Continue Straight down for 200 yards and at the end turn left into Buckingham Gate

SMi discounted rates include Continental Breakfast & VAT
£ 205.63 / Standard room / night for single occupancy
£ 229.13 Executive  room / night for single occupancy

Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.
 


associated events
MicroRNAs and Oncology Drug Development

9th June 2009, Crowne Plaza Hotel - St James, London.

Delivery of Oligonucleotide-Based Drugs

9th June 2009, Crowne Plaza Hotel - St James, London.

sponsors & supporting publications/associations:
Exiqon Febit Polyplus-Transfection   
Advacnes in Pharmalogical Sciences Bentham Science Biocompare BioScreening.com
CanBiotech CombiChem.net Drug Discovery Today European Life Science journal
GEN Genomics Proteomics HTScreening.net HUM-MOLGEN.org
Inpharm.Com In-Pharmatechnologist.com Karger Publishers Peptides.net
PharmaVOICE Pharmcast.com Pharmiweb Piribo
Report Buyer RNAi.net SelectScience.net   
costs and discounts

Conference Registration

Conference Registration - Event Registration                £1,299.00    Add to Basket
Conference Registration - Attend Day 1 Only                £999.00    Add to Basket
Conference Registration - Attend Day 2 Only                £999.00    Add to Basket
Conference Registration - Promotional Literature Distribution                £999.00    Add to Basket

Executive Briefing Registration

Executive Briefing - Delivery of Oligonucleotide-Based Drugs                £499.00    Add to Basket
Executive Briefing - MicroRNAs and Oncology Drug Development                £499.00    Add to Basket

Conference Documentation

10/06/2009 RNAi, siRNA & miRNA, Conference Documentation - PDF Documentation on CD ROM, Single User License                £499.00    Add to Basket
10/06/2009 RNAi, siRNA & miRNA, Conference Documentation - PDF Documentation on CD ROM, Site License                £1,497.00    Add to Basket